The respective sensitivity and specificity were 83.3% and 76.7% for BLACAT1 with the cutoff value of 1.177 between CRC patients and health controls, 56.7% and 92.9% with the cutoff value of 5.035 between CRC patients and non-cancer patients (Fig. 6). This evidence concerns the gene BLACAT1 and colorectal carcinoma.